Table 3.
Treatment | HR, min−1 | LVSP, mm Hg | +dP/dt, mm Hg/sec | −dP/dt, mm Hg/sec | LVEDP, mm Hg | τ, msec |
---|---|---|---|---|---|---|
Failing + Ad.βgal | 442 ± 27 | 112 ± 24 | 5,387 ± 818 | −3,748 ± 458 | 12 ± 6 | 23 ± 2 |
Failing + SERCA2a | 440 ± 21 | 147 ± 22* | 7,924 ± 1,857* | −6,782 ± 971* | 9 ± 5 | 14 ± 2* |
HR, heart rate; LVSP, left-ventricular systolic pressure; +dP/dt, maximal rate of rise of left-ventricular pressure; −dP/dt, maximal rate of decline of left-ventricular pressure; LVEDP, left-ventricular end-diastolic pressure; τ, time course of isovolumic relaxation; *, P < 0.05 compared to Failing + Ad.βgal.